Chugai Pharma Europe Ltd (CPE), is a subsidiary of Chugai Pharmaceutical Co Ltd, a leading Japanese company (member of the Roche Group) responsible for the European input to Chugai’s global product development pipeline. CPE is an integral part of developing product candidates through to Market.

The disease areas of focus for Chugai Pharma Europe Ltd reflect Chugai's Global Development Pipeline.

For each development candidate, Chugai Pharma Europe Ltd works closely with the global project members, led by a Global Project Leader, and generally comprising representatives from Japan, USA and Europe, but can be wider ranging.

As a small component of a much larger organisation, Chugai Pharma Europe Ltd is able to provide agile, specialised expertise in drug development to ensure the optimal strategy for our development projects internationally, whilst considering maximisation of shareholder value for the wider corporate group.


Fast to Proof of Concept linked to skilful collaboration using smart expertise.


Creating innovative drugs in unique ways.